Zhuang Xu, Chen Yun-Yan, Zhou Qiong, Lin Jian-Hua
Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Chin Med J (Engl). 2015 Nov 20;128(22):2998-3002. doi: 10.4103/0366-6999.168962.
Preeclampsia (PE) is a serious idiopathic disease posing a threat to both mothers and fetuses' lives during pregnancy, whose main diagnostic criteria include hypertension with proteinuria. However, American College of Obstetricians and Gynecologists (ACOG) updated the diagnostic criteria for PE and reduced the diagnostic value of proteinuria for patients with PE. Qualitative analysis of the diagnostic value of 24-h proteinuria for patients with PE in China was conducted to evaluate the diagnostic criteria value in the latest ACOG guideline.
Complete clinical data of 65 patients with hypertensive disorder in pregnancy (HDP) were collected. All patients were delivered to and hospitalized in Renji Hospital. Adverse outcome was defined in case of the emergence of any serious complication for a mother or the fetus. A retrospective study was conducted according to ACOG guideline, to analyze the relationship between each diagnostic criteria of ACOG guideline and maternal and perinatal outcomes. Spearman correlation test was used to detect the association between each diagnostic criterion, its corresponding value, and the adverse pregnancy outcome. Logistic regression was performed to verify the result of Spearman correlation test.
Of 65 HDP patients, the percentage of adverse pregnancy outcome was 63.1%. Adverse pregnancy outcomes constitute diversification. There were 55 cases with 24-h proteinuria value ≥0.3 g, of which the adverse outcome rate was 74.5%. While adverse pregnancy outcomes did not appear in the rest 10 HDP patients with proteinuria <0.3 g/24 h. The statistic difference was significant (P = 0.000). However, no significant difference was found in other criteria groups (impaired liver function: P = 0.417; renal insufficiency: P = 0.194; thrombocytopenia: P = 0.079; and cerebral or visual symptoms: P = 0.296). The correlation coefficient between 24-h proteinuria ≥0.3 g and adverse pregnancy outcomes was 0.557 (P < 0.005). Impaired liver function (P = 0.180), renal insufficiency (P = 0.077) and cerebral or visual symptoms (P = 0.118) were not related to adverse outcomes. The 24-h proteinuria value (HDP: r = 0.685; PE: r = 0.521), liver enzyme value (HDP: r = 0.519; PE: r = 0.501), and creatinine value (HDP: r = 0.511; PE: r = 0.398) were associated with adverse pregnancy outcomes both in PE and HDP, and the corresponding logistic regression equation can be produced.
The 24-h proteinuria value is still an important diagnostic criterion for PE, and deletion of 24-h proteinuria value from diagnostic criteria for severe PE was not recommended. The diagnostic criteria in ACOG guideline need to be verified in Chinese women.
子痫前期(PE)是一种严重的特发性疾病,在孕期对母亲和胎儿的生命构成威胁,其主要诊断标准包括高血压伴蛋白尿。然而,美国妇产科医师学会(ACOG)更新了PE的诊断标准,降低了蛋白尿对PE患者的诊断价值。对中国PE患者24小时蛋白尿的诊断价值进行定性分析,以评估最新ACOG指南中诊断标准的价值。
收集65例妊娠高血压疾病(HDP)患者的完整临床资料。所有患者均在仁济医院分娩并住院。若母亲或胎儿出现任何严重并发症,则定义为不良结局。根据ACOG指南进行回顾性研究,分析ACOG指南各诊断标准与孕产妇及围产儿结局之间的关系。采用Spearman相关性检验检测各诊断标准及其对应值与不良妊娠结局之间的关联。进行逻辑回归以验证Spearman相关性检验的结果。
65例HDP患者中,不良妊娠结局的比例为63.1%。不良妊娠结局构成多样化。24小时蛋白尿值≥0.3g的患者有55例,其中不良结局发生率为74.5%。其余10例24小时蛋白尿<0.3g的HDP患者未出现不良妊娠结局。差异具有统计学意义(P = 0.000)。然而,在其他标准组中未发现显著差异(肝功能损害:P = 0.417;肾功能不全:P = 0.194;血小板减少:P = 0.079;以及脑或视觉症状:P = 0.296)。24小时蛋白尿≥0.3g与不良妊娠结局之间的相关系数为0.557(P < 0.005)。肝功能损害(P = 0.180)、肾功能不全(P = 0.077)和脑或视觉症状(P = 0.118)与不良结局无关。24小时蛋白尿值(HDP:r = 0.685;PE:r = 0.521)、肝酶值(HDP:r = 0.519;PE:r = 0.501)和肌酐值(HDP:r = 0.511;PE:r = 0.398)在PE和HDP中均与不良妊娠结局相关,且可得出相应的逻辑回归方程。
24小时蛋白尿值仍然是PE的重要诊断标准,不建议从重度PE的诊断标准中删除24小时蛋白尿值。ACOG指南中的诊断标准需要在中国女性中进行验证。